Novavax to Report Q4 Earnings: Here's What You Can Expect
Novavax NVAX is expected to report fourth-quarter and full-year 2024 earnings later this month. In the last reported quarter, ...
Citrus County Chronicle Online1d
Crohn's disease and colitis explained
Inflammatory bowel disease (IBD) affects between 2.4 and 3.1 million people across the United States, according to the ...
Nature7d
The researchers on a quest to protect the gut from antibiotics
The crucial drugs can have unintended consequences. Innovative therapies could shield the microbiome from their effects.
National Institute for Health and Care Excellence21d
Healthcare-associated infections: incidence of Clostridium difficile (C. diff)
This indicator covers the incidence of healthcare associated infections from Clostridium difficile (C. diff). It measures outcomes that reflect the quality of care or processes linked by evidence to ...
Medscape23d
Emerging Therapies in the Treatment of Clostridium difficile-Associated Disease
In vitro, nitazoxanide has shown excellent activity against C. difficile. In one study, the 90% MIC (MIC 90) of the toxigenic strains of C. difficile was 0.5 µg/mL for nitazoxanide, which was ...
Medscape28d
Fidaxomicin: A New Macrocyclic, RNA Polymerase-inhibiting Antibiotic for the Treatment of Clostridium difficile Infections
Mild Clostridium difficile infection (CDI; stool frequency <four-times daily; no signs of severe colitis), clearly induced by the use of antibiotics, may be treated by stopping the inducing ...